The Cariplo Foundation awards a grant to The Laboratory of Experimental Biochemistry & Molecular Biology
The Laboratory of Experimental Biochemistry & Molecular Biology has received the 2018 grant from the “Cariplo Foundation” on “Age-related diseases” as a partner with University of Milano-Bicocca Read more…
Marta Gomarasca is awarded grant by the Fondazione Roche
Marta Gomarasca, researcher at the Laboratory of Experimental Biochemistry & Molecular Biology, has won an 18-month grant “Bando Roche per la Ricerca 2018”, conferred by Fondazione Roche, with the independent research project proposal. Read more…
Latest Research
Zebrafish Lab
Check out our recent publications
Use of innovative read-out system (scale) to study the mechanisms of bone function in physiological conditions, pathological models and pharmacological testing.
Carnovali M, Ottria R, Pasqualetti S, Banfi G, Ciuffreda P, Mariotti M. Effects of bioactive fatty acid amide derivatives in zebrafish scale model of bone metabolism and disease. Pharmacol Res. 2016 Feb;104:1-8.
…
An interesting multidisciplinary paper
Jacopo Vitale cooperated with Dr. Brayda-Bruno and the other labs at IRCCS Galeazzi in a study about the relation between vitamin D and intervertebral disc degeneration.
Brayda-Bruno M, Viganò M, Cauci S, Vitale JA, de Girolamo L, De Luca P, Lombardi G, Banfi G, Colombini A.
Plasma vitamin D and osteo-cartilaginous markers in Italian males affected by intervertebral disc degeneration: Focus on seasonal and pathological trend of type II collagen degradation.
Clin Chim Acta. 2017 May 22;471:87-93. doi: 10.1016/j.cca.2017.05.028.
Normalization strategies differently affect circulating miRNA profile associated with the training status
The Laboratory of Experimental Biochemistry & Molecular Biology, directed by Prof. Giovanni Lombardi, has just published an Open Access paper on the prestigious journal Scientific Reports. The importance of this research relies on the fact that miRNAs (short non-coding RNA molecules that finely regulate gene expression), and particularly circulating miRNAs, are next to be introduced in clinics as diagnostic/prognostic tools. Read the full paper here
